EMEA (Europe, Middle East and Africa) Muscle Relaxant Drugs Market Report 2017

EMEA (Europe, Middle East and Africa) Muscle Relaxant Drugs Market Report 2017

1 Muscle Relaxant Drugs Overview

1.1 Product Overview and Scope of Muscle Relaxant Drugs

1.2 Classification of Muscle Relaxant Drugs

1.2.1 EMEA Muscle Relaxant Drugs Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 EMEA Muscle Relaxant Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Skeletal Muscle Relaxant Drugs

1.2.4 Facial Muscle Relaxant Drugs

1.3 EMEA Muscle Relaxant Drugs Market by Application/End Users

1.3.1 EMEA Muscle Relaxant Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 EMEA Muscle Relaxant Drugs Market by Region

1.4.1 EMEA Muscle Relaxant Drugs Market Size (Value) Comparison by Region (2012-2022)

1.4.2 Europe Status and Prospect (2012-2022)

1.4.3 Middle East Status and Prospect (2012-2022)

1.4.4 Africa Status and Prospect (2012-2022)

1.5 EMEA Market Size (Value and Volume) of Muscle Relaxant Drugs (2012-2022)

1.5.1 EMEA Muscle Relaxant Drugs Sales and Growth Rate (2012-2022)

1.5.2 EMEA Muscle Relaxant Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Muscle Relaxant Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application

2.1 EMEA Muscle Relaxant Drugs Market Competition by Players/Manufacturers

2.1.1 EMEA Muscle Relaxant Drugs Sales Volume and Market Share of Major Players (2012-2017)

2.1.2 EMEA Muscle Relaxant Drugs Revenue and Share by Players (2012-2017)

2.1.3 EMEA Muscle Relaxant Drugs Sale Price by Players (2012-2017)

2.2 EMEA Muscle Relaxant Drugs (Volume and Value) by Type/Product Category

2.2.1 EMEA Muscle Relaxant Drugs Sales and Market Share by Type (2012-2017)

2.2.2 EMEA Muscle Relaxant Drugs Revenue and Market Share by Type (2012-2017)

2.2.3 EMEA Muscle Relaxant Drugs Sale Price by Type (2012-2017)

2.3 EMEA Muscle Relaxant Drugs (Volume) by Application

2.4 EMEA Muscle Relaxant Drugs (Volume and Value) by Region

2.4.1 EMEA Muscle Relaxant Drugs Sales and Market Share by Region (2012-2017)

2.4.2 EMEA Muscle Relaxant Drugs Revenue and Market Share by Region (2012-2017)

2.4.3 EMEA Muscle Relaxant Drugs Sales Price by Region (2012-2017)

3 Europe Muscle Relaxant Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application

3.1 Europe Muscle Relaxant Drugs Sales and Value (2012-2017)

3.1.1 Europe Muscle Relaxant Drugs Sales Volume and Growth Rate (2012-2017)

3.1.2 Europe Muscle Relaxant Drugs Revenue and Growth Rate (2012-2017)

3.2 Europe Muscle Relaxant Drugs Sales and Market Share by Type

3.3 Europe Muscle Relaxant Drugs Sales and Market Share by Application

3.4 Europe Muscle Relaxant Drugs Sales Volume and Value (Revenue) by Countries

3.4.1 Europe Muscle Relaxant Drugs Sales Volume by Countries (2012-2017)

3.4.2 Europe Muscle Relaxant Drugs Revenue by Countries (2012-2017)

3.4.3 Germany Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

3.4.4 France Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

3.4.5 UK Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

3.4.6 Russia Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

3.4.7 Italy Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

3.4.8 Benelux Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

4 Middle East Muscle Relaxant Drugs (Volume, Value and Sales Price), by Region, Type and Application

4.1 Middle East Muscle Relaxant Drugs Sales and Value (2012-2017)

4.1.1 Middle East Muscle Relaxant Drugs Sales Volume and Growth Rate (2012-2017)

4.1.2 Middle East Muscle Relaxant Drugs Revenue and Growth Rate (2012-2017)

4.2 Middle East Muscle Relaxant Drugs Sales and Market Share by Type

4.3 Middle East Muscle Relaxant Drugs Sales and Market Share by Application

4.4 Middle East Muscle Relaxant Drugs Sales Volume and Value (Revenue) by Countries

4.4.1 Middle East Muscle Relaxant Drugs Sales Volume by Countries (2012-2017)

4.4.2 Middle East Muscle Relaxant Drugs Revenue by Countries (2012-2017)

4.4.3 Saudi Arabia Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

4.4.4 Israel Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

4.4.5 UAE Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

4.4.6 Iran Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

5 Africa Muscle Relaxant Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application

5.1 Africa Muscle Relaxant Drugs Sales and Value (2012-2017)

5.1.1 Africa Muscle Relaxant Drugs Sales Volume and Growth Rate (2012-2017)

5.1.2 Africa Muscle Relaxant Drugs Revenue and Growth Rate (2012-2017)

5.2 Africa Muscle Relaxant Drugs Sales and Market Share by Type

5.3 Africa Muscle Relaxant Drugs Sales and Market Share by Application

5.4 Africa Muscle Relaxant Drugs Sales Volume and Value (Revenue) by Countries

5.4.1 Africa Muscle Relaxant Drugs Sales Volume by Countries (2012-2017)

5.4.2 Africa Muscle Relaxant Drugs Revenue by Countries (2012-2017)

5.4.3 South Africa Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

5.4.4 Nigeria Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

5.4.5 Egypt Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

5.4.6 Algeria Muscle Relaxant Drugs Sales and Growth Rate (2012-2017)

6 EMEA Muscle Relaxant Drugs Manufacturers/Players Profiles and Sales Data

6.1 Pfizer

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Muscle Relaxant Drugs Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Pfizer Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Allergan

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Muscle Relaxant Drugs Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Allergan Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Ipsen Group

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Muscle Relaxant Drugs Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Ipsen Group Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Teva Pharmaceuticals

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Muscle Relaxant Drugs Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Teva Pharmaceuticals Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Novartis

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Muscle Relaxant Drugs Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Novartis Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Johnson & Johnson

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Muscle Relaxant Drugs Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Johnson & Johnson Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Takeda Pharmaceutical

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Muscle Relaxant Drugs Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Takeda Pharmaceutical Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Sun Pharmaceutical Industries

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Muscle Relaxant Drugs Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Sun Pharmaceutical Industries Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Merz Pharma

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Muscle Relaxant Drugs Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Merz Pharma Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Mylan

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Muscle Relaxant Drugs Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Mylan Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Fresenius Kabi

6.12 Endo International

6.13 Par Sterile Products

6.14 Acorda Therapeutics

6.15 SteriMax Inc

6.16 Emcure Pharmaceuticals

6.17 Upsher-Smith Laboratories

6.18 Orient Pharma

6.19 Daewoong Pharmaceutical

7 Muscle Relaxant Drugs Manufacturing Cost Analysis

7.1 Muscle Relaxant Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Muscle Relaxant Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Muscle Relaxant Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Muscle Relaxant Drugs Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 EMEA Muscle Relaxant Drugs Market Forecast (2017-2022)

11.1 EMEA Muscle Relaxant Drugs Sales, Revenue and Price Forecast (2017-2022)

11.1.1 EMEA Muscle Relaxant Drugs Sales and Growth Rate Forecast (2017-2022)

11.1.2 EMEA Muscle Relaxant Drugs Revenue and Growth Rate Forecast (2017-2022)

11.1.3 EMEA Muscle Relaxant Drugs Price and Trend Forecast (2017-2022)

11.2 EMEA Muscle Relaxant Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.3 Europe Muscle Relaxant Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.4 Middle Eastt Muscle Relaxant Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.5 Africa Muscle Relaxant Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.6 EMEA Muscle Relaxant Drugs Sales Forecast by Type (2017-2022)

11.7 EMEA Muscle Relaxant Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Muscle Relaxant Drugs

Figure EMEA Muscle Relaxant Drugs Sales Volume (K Pcs) by Type (2012-2022)

Figure EMEA Muscle Relaxant Drugs Sales Volume Market Share by Type (Product Category) in 2016

Figure Skeletal Muscle Relaxant Drugs Product Picture

Figure Facial Muscle Relaxant Drugs Product Picture

Figure EMEA Muscle Relaxant Drugs Sales Volume (K Pcs) by Application (2012-2022)

Figure EMEA Sales Market Share of Muscle Relaxant Drugs by Application in 2016

Figure Hospital Pharmacies Examples

Table Key Downstream Customer in Hospital Pharmacies

Figure Retail Pharmacies Examples

Table Key Downstream Customer in Retail Pharmacies

Figure Other Examples

Table Key Downstream Customer in Other

Figure EMEA Muscle Relaxant Drugs Market Size (Million USD) by Region (2012-2022)

Figure Europe Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Muscle Relaxant Drugs Revenue (Million USD) Status and Forecast by Countries

Figure Middle East Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Middle East Muscle Relaxant Drugs Revenue (Million USD) Status and Forecast by Countries

Figure Africa Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Africa Muscle Relaxant Drugs Revenue (Million USD) Status and Forecast by Countries

Figure EMEA Muscle Relaxant Drugs Sales Volume and Growth Rate (2012-2022)

Figure EMEA Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure EMEA Muscle Relaxant Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table EMEA Muscle Relaxant Drugs Sales Volume (K Pcs) of Major Players (2012-2017)

Table EMEA Muscle Relaxant Drugs Sales Share by Players (2012-2017)

Figure 2016 Muscle Relaxant Drugs Sales Share by Players

Figure 2017 Muscle Relaxant Drugs Sales Share by Players

Figure EMEA Muscle Relaxant Drugs Market Major Players Product Revenue (Million USD) (2012-2017)

Table EMEA Muscle Relaxant Drugs Revenue (Million USD) by Players (2012-2017)

Table EMEA Muscle Relaxant Drugs Revenue Share by Players (2012-2017)

Table 2016 EMEA Muscle Relaxant Drugs Revenue Share by Players

Table 2017 EMEA Muscle Relaxant Drugs Revenue Share by Players

Table EMEA Muscle Relaxant Drugs Sale Price (USD/Pcs) by Players (2012-2017)

Table EMEA Muscle Relaxant Drugs Sales (K Pcs) and Market Share by Type (2012-2017)

Table EMEA Muscle Relaxant Drugs Sales Share by Type (2012-2017)

Figure Sales Market Share of Muscle Relaxant Drugs by Type (2012-2017)

Figure EMEA Muscle Relaxant Drugs Sales Market Share by Type (2012-2017)

Table EMEA Muscle Relaxant Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table EMEA Muscle Relaxant Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Muscle Relaxant Drugs by Type in 2016

Table EMEA Muscle Relaxant Drugs Sale Price (USD/Pcs) by Type (2012-2017)

Table EMEA Muscle Relaxant Drugs Sales (K Pcs) and Market Share by Application (2012-2017)

Table EMEA Muscle Relaxant Drugs Sales Share by Application (2012-2017)

Figure Sales Market Share of Muscle Relaxant Drugs by Application (2012-2017)

Figure EMEA Muscle Relaxant Drugs Sales Market Share by Application in 2016

Table EMEA Muscle Relaxant Drugs Sales (K Pcs) and Market Share by Region (2012-2017)

Table EMEA Muscle Relaxant Drugs Sales Share by Region (2012-2017)

Figure Sales Market Share of Muscle Relaxant Drugs by Region (2012-2017)

Figure EMEA Muscle Relaxant Drugs Sales Market Share in 2016

Table EMEA Muscle Relaxant Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table EMEA Muscle Relaxant Drugs Revenue Share by Region (2012-2017)

Figure Revenue Market Share of Muscle Relaxant Drugs by Region (2012-2017)

Figure EMEA Muscle Relaxant Drugs Revenue Market Share Regions in 2016

Table EMEA Muscle Relaxant Drugs Sales Price (USD/Pcs) by Region (2012-2017)

Figure Europe Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Europe Muscle Relaxant Drugs Revenue and Growth Rate (2012-2017)

Table Europe Muscle Relaxant Drugs Sales (K Pcs) by Type (2012-2017)

Table Europe Muscle Relaxant Drugs Market Share by Type (2012-2017)

Figure Europe Muscle Relaxant Drugs Market Share by Type in 2016

Table Europe Muscle Relaxant Drugs Sales (K Pcs) by Application (2012-2017)

Table Europe Muscle Relaxant Drugs Market Share by Application (2012-2017)

Figure Europe Muscle Relaxant Drugs Market Share by Application in 2016

Table Europe Muscle Relaxant Drugs Sales (K Pcs) by Countries (2012-2017)

Table Europe Muscle Relaxant Drugs Sales Market Share by Countries (2012-2017)

Figure Europe Muscle Relaxant Drugs Sales Market Share by Countries (2012-2017)

Figure Europe Muscle Relaxant Drugs Sales Market Share by Countries in 2016

Table Europe Muscle Relaxant Drugs Revenue (Million USD) by Countries (2012-2017)

Table Europe Muscle Relaxant Drugs Revenue Market Share by Countries (2012-2017)

Figure Europe Muscle Relaxant Drugs Revenue Market Share by Countries (2012-2017)

Figure Europe Muscle Relaxant Drugs Revenue Market Share by Countries in 2016

Figure Germany Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure France Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure UK Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Russia Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Italy Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Benelux Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Middle East Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Middle East Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Table Middle East Muscle Relaxant Drugs Sales (K Pcs) by Type (2012-2017)

Table Middle East Muscle Relaxant Drugs Market Share by Type (2012-2017)

Figure Middle East Muscle Relaxant Drugs Market Share by Type (2012-2017)

Table Middle East Muscle Relaxant Drugs Sales (K Pcs) by Applications (2012-2017)

Table Middle East Muscle Relaxant Drugs Market Share by Applications (2012-2017)

Figure Middle East Muscle Relaxant Drugs Sales Market Share by Application in 2016

Table Middle East Muscle Relaxant Drugs Sales Volume (K Pcs) by Countries (2012-2017)

Table Middle East Muscle Relaxant Drugs Sales Volume Market Share by Countries (2012-2017)

Figure Middle East Muscle Relaxant Drugs Sales Volume Market Share by Countries in 2016

Table Middle East Muscle Relaxant Drugs Revenue (Million USD) by Countries (2012-2017)

Table Middle East Muscle Relaxant Drugs Revenue Market Share by Countries (2012-2017)

Figure Middle East Muscle Relaxant Drugs Revenue Market Share by Countries (2012-2017)

Figure Middle East Muscle Relaxant Drugs Revenue Market Share by Countries in 2016

Figure Saudi Arabia Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Israel Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure UAE Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Iran Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Africa Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Africa Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Table Africa Muscle Relaxant Drugs Sales (K Pcs) by Type (2012-2017)

Table Africa Muscle Relaxant Drugs Sales Market Share by Type (2012-2017)

Figure Africa Muscle Relaxant Drugs Sales Market Share by Type (2012-2017)

Figure Africa Muscle Relaxant Drugs Sales Market Share by Type in 2016

Table Africa Muscle Relaxant Drugs Sales (K Pcs) by Application (2012-2017)

Table Africa Muscle Relaxant Drugs Sales Market Share by Application (2012-2017)

Figure Africa Muscle Relaxant Drugs Sales Market Share by Application (2012-2017)

Table Africa Muscle Relaxant Drugs Sales Volume (K Pcs) by Countries (2012-2017)

Table Africa Muscle Relaxant Drugs Sales Market Share by Countries (2012-2017)

Figure Africa Muscle Relaxant Drugs Sales Market Share by Countries (2012-2017)

Figure Africa Muscle Relaxant Drugs Sales Market Share by Countries in 2016

Table Africa Muscle Relaxant Drugs Revenue (Million USD) by Countries (2012-2017)

Table Africa Muscle Relaxant Drugs Revenue Market Share by Countries (2012-2017)

Figure Africa Muscle Relaxant Drugs Revenue Market Share by Countries (2012-2017)

Figure Africa Muscle Relaxant Drugs Revenue Market Share by Countries in 2016

Figure South Africa Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Nigeria Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Egypt Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Algeria Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Table Pfizer Muscle Relaxant Drugs Basic Information List

Table Pfizer Muscle Relaxant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Pfizer Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Pfizer Muscle Relaxant Drugs Sales Market Share in EMEA (2012-2017)

Figure Pfizer Muscle Relaxant Drugs Revenue Market Share in EMEA (2012-2017)

Table Allergan Muscle Relaxant Drugs Basic Information List

Table Allergan Muscle Relaxant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Allergan Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Allergan Muscle Relaxant Drugs Sales Market Share in EMEA (2012-2017)

Figure Allergan Muscle Relaxant Drugs Revenue Market Share in EMEA (2012-2017)

Table Ipsen Group Muscle Relaxant Drugs Basic Information List

Table Ipsen Group Muscle Relaxant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Ipsen Group Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Ipsen Group Muscle Relaxant Drugs Sales Market Share in EMEA (2012-2017)

Figure Ipsen Group Muscle Relaxant Drugs Revenue Market Share in EMEA (2012-2017)

Table Teva Pharmaceuticals Muscle Relaxant Drugs Basic Information List

Table Teva Pharmaceuticals Muscle Relaxant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Teva Pharmaceuticals Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Teva Pharmaceuticals Muscle Relaxant Drugs Sales Market Share in EMEA (2012-2017)

Figure Teva Pharmaceuticals Muscle Relaxant Drugs Revenue Market Share in EMEA (2012-2017)

Table Novartis Muscle Relaxant Drugs Basic Information List

Table Novartis Muscle Relaxant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Novartis Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Novartis Muscle Relaxant Drugs Sales Market Share in EMEA (2012-2017)

Figure Novartis Muscle Relaxant Drugs Revenue Market Share in EMEA (2012-2017)

Table Johnson & Johnson Muscle Relaxant Drugs Basic Information List

Table Johnson & Johnson Muscle Relaxant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Johnson & Johnson Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Johnson & Johnson Muscle Relaxant Drugs Sales Market Share in EMEA (2012-2017)

Figure Johnson & Johnson Muscle Relaxant Drugs Revenue Market Share in EMEA (2012-2017)

Table Takeda Pharmaceutical Muscle Relaxant Drugs Basic Information List

Table Takeda Pharmaceutical Muscle Relaxant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Takeda Pharmaceutical Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Takeda Pharmaceutical Muscle Relaxant Drugs Sales Market Share in EMEA (2012-2017)

Figure Takeda Pharmaceutical Muscle Relaxant Drugs Revenue Market Share in EMEA (2012-2017)

Table Sun Pharmaceutical Industries Muscle Relaxant Drugs Basic Information List

Table Sun Pharmaceutical Industries Muscle Relaxant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Sun Pharmaceutical Industries Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Sun Pharmaceutical Industries Muscle Relaxant Drugs Sales Market Share in EMEA (2012-2017)

Figure Sun Pharmaceutical Industries Muscle Relaxant Drugs Revenue Market Share in EMEA (2012-2017)

Table Merz Pharma Muscle Relaxant Drugs Basic Information List

Table Merz Pharma Muscle Relaxant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Merz Pharma Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Merz Pharma Muscle Relaxant Drugs Sales Market Share in EMEA (2012-2017)

Figure Merz Pharma Muscle Relaxant Drugs Revenue Market Share in EMEA (2012-2017)

Table Mylan Muscle Relaxant Drugs Basic Information List

Table Mylan Muscle Relaxant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Mylan Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate (2012-2017)

Figure Mylan Muscle Relaxant Drugs Sales Market Share in EMEA (2012-2017)

Figure Mylan Muscle Relaxant Drugs Revenue Market Share in EMEA (2012-2017)

Table Fresenius Kabi Muscle Relaxant Drugs Basic Information List

Table Endo International Muscle Relaxant Drugs Basic Information List

Table Par Sterile Products Muscle Relaxant Drugs Basic Information List

Table Acorda Therapeutics Muscle Relaxant Drugs Basic Information List

Table SteriMax Inc Muscle Relaxant Drugs Basic Information List

Table Emcure Pharmaceuticals Muscle Relaxant Drugs Basic Information List

Table Upsher-Smith Laboratories Muscle Relaxant Drugs Basic Information List

Table Orient Pharma Muscle Relaxant Drugs Basic Information List

Table Daewoong Pharmaceutical Muscle Relaxant Drugs Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Muscle Relaxant Drugs

Figure Manufacturing Process Analysis of Muscle Relaxant Drugs

Figure Muscle Relaxant Drugs Industrial Chain Analysis

Table Raw Materials Sources of Muscle Relaxant Drugs Major Manufacturers in 2016

Table Major Buyers of Muscle Relaxant Drugs

Table Distributors/Traders List

Figure EMEA Muscle Relaxant Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)

Figure EMEA Muscle Relaxant Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure EMEA Muscle Relaxant Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)

Table EMEA Muscle Relaxant Drugs Sales (K Pcs) Forecast by Region (2017-2022)

Figure EMEA Muscle Relaxant Drugs Sales Market Share Forecast by Region (2017-2022)

Table EMEA Muscle Relaxant Drugs Revenue (Million USD) Forecast by Region (2017-2022)

Figure EMEA Muscle Relaxant Drugs Revenue Market Share Forecast by Region (2017-2022)

Table Europe Muscle Relaxant Drugs Sales (K Pcs) Forecast by Countries (2017-2022)

Figure Europe Muscle Relaxant Drugs Sales Market Share Forecast by Countries (2017-2022)

Table Europe Muscle Relaxant Drugs Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Europe Muscle Relaxant Drugs Revenue Market Share Forecast by Countries (2017-2022)

Table Middle East Muscle Relaxant Drugs Sales (K Pcs) Forecast by Countries (2017-2022)

Figure Middle East Muscle Relaxant Drugs Sales Market Share Forecast by Countries (2017-2022)

Table Middle East Muscle Relaxant Drugs Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Middle East Muscle Relaxant Drugs Revenue Market Share Forecast by Countries (2017-2022)

Table Africa Muscle Relaxant Drugs Sales (K Pcs) Forecast by Countries (2017-2022)

Figure Africa Muscle Relaxant Drugs Sales Market Share Forecast by Countries (2017-2022)

Table Africa Muscle Relaxant Drugs Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Africa Muscle Relaxant Drugs Revenue Market Share Forecast by Countries (2017-2022)

Table EMEA Muscle Relaxant Drugs Sales (K Pcs) Forecast by Type (2017-2022)

Figure EMEA Muscle Relaxant Drugs Sales Market Share Forecast by Type (2017-2022)

Table EMEA Muscle Relaxant Drugs Sales (K Pcs) Forecast by Application (2017-2022)

Figure EMEA Muscle Relaxant Drugs Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources